INCY Incyte Corporation

INCY Incyte Corporation

Healthcare · Biotechnology

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 neutral converging

POC $97.18 · VWAP $105.10 · +7.6% vs 12m avg buyer

basing vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster EVP, President sold $10.5M, Aug 4–14

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

INCY Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist INCY belongs to, members best 30-day change first — INCY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings INCY reports in 12 days Oct 29

Against street estimates

How INCY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 28 · projection Oct 16

Result
Jul 28 2.153.09+44.0%Beat
Apr 28 1.341.81+35.1%Beat
Feb 10 1.921.80-6.1%Miss
Oct 28 '25 1.642.26+38.0%Beat
Jul 29 '25 1.471.57+6.6%Beat
Apr 29 '25 1.031.16 GAAP ≠ +12.3%Beat
Feb 10 '25 1.551.43-8.0%Miss
Oct 29 '24 1.091.07 GAAP ≠ -2.0%Miss

Recent news

Headlines about INCY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 8 days ago · Oct 9

Types
Jul 28 Catalyst INCY earnings